Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,666 | 0 | 52 | 456 | 43 |
| Cost of Goods | 1,577 | N/A | N/A | N/A | N/A |
| Gross Profit | 89 | N/A | 52 | 456 | 43 |
| Operating Expenses | 51,795 | 48,741 | 42,256 | 38,505 | 28,338 |
| Operating Income | -51,129 | -48,741 | -42,204 | -38,049 | -28,295 |
| Other Income | 7,321 | 7,315 | 7,752 | 6,251 | 7,890 |
| Pre-tax Income | -43,808 | -41,426 | -34,452 | -31,798 | -20,405 |
| Net Income Continuous | -43,808 | -41,426 | -34,452 | -31,798 | -20,405 |
| Net Income | $-43,808 | $-41,426 | $-34,452 | $-31,798 | $-20,405 |
| EPS Basic Total Ops | -0.57 | -0.54 | -0.45 | -0.47 | -0.30 |
| EPS Basic Continuous Ops | -0.57 | -0.54 | -0.45 | -0.46 | -0.30 |
| EPS Diluted Total Ops | -0.57 | -0.54 | -0.45 | -0.47 | -0.30 |
| EPS Diluted Continuous Ops | -0.57 | -0.54 | -0.45 | -0.46 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.54 | -0.45 | -0.48 | -0.30 |
| EBITDA(a) | $-50,512 | $-50,472 | $-42,459 | $-36,794 | $-29,856 |